Safety, efficacy and kinetics of perampanel as therapy in adolescents with partial seizures

Seizures are abnormal electrical impulses in the brain. The signs and symptoms of seizures vary depending on the type of seizure a patient has. This study is looking at the use of perampanel in adolescents that have partial-onset seizures that are not currently controlled

Medication Under Study:
Perampanel (E2007)

Full study title:
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study With an Open-label Extension Phase to Evaluate the Effect of Perampanel (E2007) on Cognition, Growth, Safety, Tolerability, and Pharmacokinetics When Administered as an Adjunctive Therapy in Adolescents (12 to less than 18 years of age) With Inadequately Controlled Partial-onset Seizures

IRB Study ID:

Who may qualify:

Adolescent patients, 12-18 years of age, that have been diagnosed with partial-onset seizures currently being treated with other antiepileptic medications

Who does not qualify:

Patients under 12 or over 18 years of age with other seizure types or medical conditions

If you are interested in this study or have questions about your child's eligibility, please contact:

Rebecca D. Considine Research Institute, 330-543-5012

For urgent patient care matters involving a current study patient, please call: 330-920-5774

Lead Principal Investigator:

Thomas Enlow, MD
Pediatric Neurologist

Bookmark and Share

iGrow iGrow
Sign up for our parent enewsletter
    Contact Us



    find a location
    Find a location Type the first 3-5 letters of a specialty, service or location:
    Or, view: a map, a list of all locations, locations by city or locations near me.
    find a doctor
    Find a doctor Type the first 3-5 letters of the name, location or specialty:
    Or, view a list of all doctors by name, location and specialty.